Table 3. European Incidence Rate of FTLD Phenotype Cases per 100 000 Person-Yearsa.
Phenotype | Total | Rate (95% CI), cases per 100 000 person-years | Random-intercept variance, sex-adjusted model | ||
---|---|---|---|---|---|
Rate (95% CI), cases per 100 000 person-years | Random-intercept variance | Male | Female | ||
BVFTD | 0.83 (0.52-1.32) | 0.48 | 0.99 (0.60-1.62) | 0.67 (0.40-1.13) | 0.48 |
PPA | 0.61 (0.42-0.88) | 0.15 | 0.74 (0.49-1.12) | 0.48 (0.31-0.76) | 0.15 |
CBS or PSP | 0.51 (0.22-1.20) | 1.94 | 0.59 (0.25-1.41) | 0.44 (0.18-1.06) | 1.93 |
FTD-ALS | 0.11 (0.05-0.26) | 0.81 | 0.16 (0.06-0.39) | 0.08 (0.03-0.23) | 0.80 |
Abbreviations: BVFTD, behavioral variant frontotemporal dementia; CBS, corticobasal syndrome; FTD-ALS, frontotemporal dementia with amyotrophic lateral sclerosis; FTLD, frontotemporal lobar degeneration; PPA, primary progressive aphasia; PSP, progressive supranuclear palsy.
Estimates of incidence and sex-specific incidence are derived from random-intercept Poisson models. The estimated variance of the random intercept (measure of incidence heterogeneity across registries) is also reported.